Clinical Trial Update: Phase IIa Study for IPG11406 in Patients With Lupus Nephritis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for IPG11406 in patients with lupus nephritis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• IPG11406

Snippet

Sponsor: Nanjing Immunophage Biotech Co., Ltd | Conditions: Lupus Nephritis | Phase 1, Phase 2 | Status: RECRUITING